Planning Grants for Translational Research for the Prevention and Control of Diabetes and Obesity (R34)

Post Date

April 28th 2009

Application Due Date

March 1st 2012

Funding Opportunity Number

PAR-09-177

CFDA Number(s)

93.847
93.865

Funding Instrument Type(s)

Grant

Funding Activity Categories

Food and Nutrition
Health
Income Security and Social Services

Eligibility Categories

State Governments
County Governments
City or Township Governments
Special District Governments
Independent School Districts
Public and State Controlled Institutions of Higher Education
Federally Recognized Native American Tribal Governments
Public Housing Authorities or Indian Housing Authorities
Non-Federally Recognized Native American Tribal Organizations
Non-Profits With 501 (c) (3) Status With The IRS (Except Higher Education Institutions)
Non-Profits Without 501 (c) (3) Status With The IRS (Except Higher Education Institutions)
Private Institutions of Higher Education
For-Profit Organizations (Except Small Businesses)
Small Businesses
Other

Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.

Funding

• Award Range:

  $None - $300000

Grant Description

Purpose. The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) and the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) and the Office of Behavioral and Social Sciences Research (OBSSR) encourage NIH Clinical Trial Planning Grant Program grant (R34) applications from institutions/ organizations to develop and pilot test translational interventions for the prevention and control of diabetes and obesity that have a high potential to be adopted, and sustained in applied health care settings. Research must be based on widely accepted interventions previously demonstrated to be efficacious in clinical trials. Research must target the prevention or reversal of obesity, prevention of type 2 diabetes, improved care of type 1 and type 2 diabetes, or the prevention or delay of the complications of these conditions. The interventions proposed under this FOA should have the potential to be widely disseminated to clinical practice, individuals and communities at risk. Mechanism of Support. This FOA will utilize the NIH Clinical Trial Planning Grant Program (R34) grant mechanism and runs in parallel with a R18 FOA of identical scientific scope, PAR-09-176.

Contact Information

• Agency

  Department of Health and Human Services

• Office:

  National Institutes of Health

• Agency Contact:

  NIH OER Webmaster
  FBOWebmaster@OD.NIH.GOV
  

• Agency Mailing Address:

  If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster

• Agency Email Address:

  FBOWebmaster@OD.NIH.GOV

• More Information:

  http://grants.nih.gov/grants/guide/pa-files/PAR-09-177.html